Phosphonate nucleotide compound
US6194398A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 17, 1999 |
| Grant date | Feb 27, 2001 |
| Priority date | — |
| Expiry date | Jun 17, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A phosphonate nucleotide compound represented by formula (I): ##STR1## (wherein R.sup.1 is a C.sub.1 -C.sub.6 alkyl group or the like, R.sup.2 is a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group substituted by one or more halogen atoms or the like, R.sup.3 is a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group substituted by one or more halogen atoms or the like, R.sup.4 is a hydrogen atom, a C.sub.1 -C.sub.4 alkyl group substituted by one or more halogen atoms and X is a carbon atom or a nitrogen atom), a salt thereof, a hydrate thereof or a solvate thereof, as well as a medicament containing the same. It is useful as an antiviral agent for human immunodeficiency virus, herpes simplex virus, hepatitis B virus or the like and as an antitumor agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.